Protagonist Therapeutics, Inc.

This early-stage trial is testing a new drug, PN-881, in 142 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo as a single dose or multiple doses. The study is not designed to treat any disease but to gather …